What have we learned in the 3 years of the COVID-19 pandemic?
Herz. 2023 Jun;48(3):169-172. doi: 10.1007/s00059-023-05185-3. Epub 2023 Jun 14.NO ABSTRACTPMID:37314505 | DOI:10.1007/s00059-023-05185-3 (Source: Herz)
Source: Herz - June 14, 2023 Category: Cardiology Authors: Bernhard Maisch Rolf D örr Source Type: research
Cardiovascular pharmacotherapy in old age
This article describes the options and special features of pharmacotherapy for hypertension, chronic heart failure and dyslipidemia, as well as antithrombotic treatment in (very) old people.PMID:37306716 | DOI:10.1007/s00059-023-05191-5 (Source: Herz)
Source: Herz - June 12, 2023 Category: Cardiology Authors: Martin Schulz Dietmar Trenk Ulrich Laufs Source Type: research
The COVID-19 pandemic in China: from dynamic zero-COVID to current policy
Herz. 2023 Jun 9:1-3. doi: 10.1007/s00059-023-05183-5. Online ahead of print.ABSTRACTOn 8 January 2023, after 3 years of pandemic control, China changed its management of COVID-19, applying measures against class B infectious diseases instead of Class A infectious diseases. This signaled the end of the dynamic zero-COVID policy and the reopening of the country. With a population of 1.41 billion, China's reopening policy during the COVID-19 pandemic has been characterized by a scientific, gradual, and cautious approach. Several factors contributed to the reopening policy, including an expansion of healthcare capacity, the w...
Source: Herz - June 9, 2023 Category: Cardiology Authors: Junbo Ge Source Type: research
The COVID-19 pandemic in China: from dynamic zero-COVID to current policy
Herz. 2023 Jun 9. doi: 10.1007/s00059-023-05183-5. Online ahead of print.ABSTRACTOn 8 January 2023, after 3 years of pandemic control, China changed its management of COVID-19, applying measures against class B infectious diseases instead of Class A infectious diseases. This signaled the end of the dynamic zero-COVID policy and the reopening of the country. With a population of 1.41 billion, China's reopening policy during the COVID-19 pandemic has been characterized by a scientific, gradual, and cautious approach. Several factors contributed to the reopening policy, including an expansion of healthcare capacity, the wides...
Source: Herz - June 9, 2023 Category: Cardiology Authors: Junbo Ge Source Type: research
Pulmonary hypertension associated with left heart disease
In conclusion, precise clinical and hemodynamic characterization and detailed phenotyping are essential for prognostication and the management of patients with PH-LHD.PMID:37289211 | DOI:10.1007/s00059-023-05189-z (Source: Herz)
Source: Herz - June 8, 2023 Category: Cardiology Authors: Max Wissm üller Johannes Dohr Joana Adler Laurin Ochs Tobias Tichelb äcker Christopher Hohmann Stephan Baldus Stephan Rosenkranz Source Type: research
Has COVID-19 changed the spectrum of arrhythmias and the incidence of sudden cardiac death?
Herz. 2023 Jun 5:1-6. doi: 10.1007/s00059-023-05186-2. Online ahead of print.ABSTRACTArrhythmic manifestations of COVID-19 include atrial arrhythmias such as atrial fibrillation or atrial flutter, sinus node dysfunction, atrioventricular conduction abnormalities, ventricular tachyarrhythmias, sudden cardiac arrest, and cardiovascular dysautonomias including the so-called long COVID syndrome. Various pathophysiological mechanisms have been implicated, such as direct viral invasion, hypoxemia, local and systemic inflammation, changes in ion channel physiology, immune activation, and autonomic dysregulation. The development o...
Source: Herz - June 5, 2023 Category: Cardiology Authors: Karl-Heinz Kuck Michael Schl üter Julia Vogler Christian Hendrik Heeger Roland Richard Tilz Source Type: research
